Articles in Stocks

Zacks.com

Will Toll Brothers (TOL) Earnings Disappoint in Q3? - Analyst Blog

Toll Brothers Inc. ( TOL ) is set to release its third quarter fiscal 2014 results on Sep 3, before the market opens. Last quarter, it posted a positive surprise. Let's see how things are shaping... Read >>

Motley Fool

This New Novartis AG Drug May Revolutionize Heart Failure Treatment

Doctors have long struggled to effectively treat heart failure caused by high blood pressure. ACE inhibitors, like enalapril formerly sold by Merck as the branded drug Vasotec, came on the... Read >>

Zacks.com

Novartis Releases Positive Data on LCZ696 for Heart Failure - Analyst Blog

Novartis ( NVS ) announced positive data on its pipeline candidate, LCZ696 from its PARADIGM HF study. The data was published in the New England Journal of Medicine .  PARADIGM HF is a randomized... Read >>

Zacks.com

Google Android One Phones to Debut in India - Analyst Blog

Google ( GOOGL ) is likely to unveil its much awaited low cost smartphones in India this month, thus intensifying competition in the thriving multi billion dollar smart devices market in the... Read >>

Zacks.com

ONEOK Partners Hits 52-Week High on Midstream Business - Analyst Blog

On Aug 29, 2014, the units of ONEOK Partners, L.P. ( OKS ) touched a 52 week high of $59.53. The units finally closed at $59.43, up 1.0% from the previous day's closing of $58.83. The... Read >>

Zacks.com

Ladder Capital Down to Strong Sell on Increasing Expense - Analyst Blog

On Sep 2, 2014, Zacks Investment Research downgraded Ladder Capital Corp. ( LADR ) by a notch to a Zacks Rank #5 (Strong Sell). Why the Downgrade? Ladder Capital has been experiencing downward... Read >>

Zacks.com

Wall Street Banks Get Rid of Aluminum Price Fixing Suits - Analyst Blog

Amid heightened regulatory and political scrutiny on banks' ownership of the physical commodity business, the latest dismissal of an antitrust lawsuit brings relief for Goldman Sachs Group, Inc. (... Read >>

Motley Fool

Is Microsoft's Windows Phone Bound to Be a Flop?

Microsoft had high hopes for Windows Phone when it acquired Nokia 's handset business last year. At the time, Microsoft believed it could take as much as 15% of the global smartphone market by... Read >>

Zacks.com

UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - Analyst Blog

UCB 's ( UCBJF ) Vimpat has been approved in the U.S. as monotherapy for the treatment of partial onset seizures in epilepsy patients aged 17 years and above. Vimpat is already approved in the... Read >>

Motley Fool

Top 10 Theme Parks: Disney Dominates and Is About to Get Even Better

Disney's Florida theme park. Photo Disney What's the best theme park in the world? If you are taking your family on a vacation, many sites will offer a list of the most popular... Read >>